Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Migraine With Aura and Causal or Incidental Patent Foramen Ovale (PFO): Identification of Biomarker(s) to Select Patients Who Would Most Benefit From PFO Closure. The MANET Study

NCT06046508 is registered in ClinicalTrials.gov with Centro Cardiologico Monzino as lead sponsor.

NCT NCT06046508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06046508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Migraine With Aura and Causal or Incidental Patent Foramen Ovale (PFO): Identification of Biomarker(s) to Select Patients Who Would Most Benefit From PFO Closure. The MANET Study
Lead sponsor
Centro Cardiologico Monzino
Phase
Observational
Overall status
Unknown status
Start date
May 18, 2023
Completion date
April 30, 2025
Enrollment
120 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

migraine headache, pfo - patent foramen ovale